Jobs

Adhoc Staff, Clinical Laboratory - Biotech Unit at the Institute of Human Virology Nigeria (IHVN)


The Institute of Human Virology Nigeria (IHVN) is a leading and reputable non-governmental organization addressing infectious and non-infectious diseases such as HIV, tuberculosis (TB) and cancer through the provision of prevention, diagnosis, treatment, capacity building, research, and care and support services.

We are recruiting to fill the position below:

 

Job Title: Adhoc Staff, Clinical Laboratory - Biotech Unit

Location: Abuja
Employment Type: Full time

Job Summary

  • The Adhoc Clinical Laboratory - Biotech Unit will assist the Biotech Unit in the installation, maintenance, and calibration of Laboratory ancillary equipment in IHVN-supported Laboratories.
  • Make daily reports of day-to-day activities at the IHVN equipment calibration centre/workshop and update Laboratory equipment inventory.  

Description and objectives

  • Under the supervision of the HoU-Biotech and guided by the HoD Laboratory, the Adhoc staff in the Clinical Lab - Biotech Unit will support in routine maintenance of ancillary laboratory equipment in IHVN-supported laboratories.
  • The objective is to enhance and reinforce sustainable equipment maintenance, ultimately improving the functionality of equipment in supported facilities and the overall laboratory program.

Responsibilities

  • Ability to carry out basic troubleshooting on Laboratory equipment.
  • Support Routine maintain of laboratory equipment and the e- inventory.
  • Generate Technical report.
  • Any other task(s) assigned by the Head of Unit.

Required competencies

  • Must be a graduate (BSC, BTech or HND)
  • Proficiency in Microsoft Word, Excel, and PowerPoint.

 

How to Apply
Interested and qualified candidates should send their Application Letter and detailed Curriculum Vitae in Microsoft Word format to "The Assistant Director, Human Resources" via: [email protected] using the Job Title as the subject of the mail

Application Deadline  31st January, 2024.